Journals / Ulusal Cerrahi Dergisi / 2009 / Cilt: 25 - Sayı: 3

The results of D1 versus D2 dissection in the management of gastric cancer was evaluated retrospectively for morbidity and mortality

Mide kanserinde standart D2 diseksiyona karşı D1 diseksiyonun mortalite ve morbidite çalışması

Pages
87–91
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The overall operative mortality rates for D1 and D2 dissections were 2,1 and 0 %, respectively (p>0.05).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: The chance to get healing in stomach cancer is possible with curative surgical resection.
📊
Key Findings & Data:In this study we aimed to analyze the mortality and morbidity rates between D1 dissection and D2 dissection retrospectively.
💡
Conclusion & Impact:The overall operative mortality rates for D1 and D2 dissections were 2,1 and 0 %, respectively (p>0.05).
🔬Design:Review & Systematic Survey
📍Scope:2000 Verileri
⚙️Variables:Sindirim sistemi cerrahi işlemleri · Hastalık oranı · Ölüm oranı

Abstract

Purpose: The chance to get healing in stomach cancer is possible with curative surgical resection. In this study we aimed to analyze the mortality and morbidity rates between D1 dissection and D2 dissection retrospectively. Materials and Methods: Between 2000 and 2009, 112 patients with gastric cancer who underwent D1 or D2 dissection were evaluated retrospectively. Surgery procedure and pathological classification were performed in accordance with the Japanese Classification of Gastric Carcinoma. The postoperative mortality and morbidity were analysed retrospectively. Results: In our clinic, the data of 131 patients, who had the diagnosis of gastric carcinoma, were reviewed retrospectively. 112 patients who fitted to the criteria of this study were included. Of the 112 patients, 47 went under D1 dissection, while 67 patients went under D2 resection. The overall operative mortality rates for D1 and D2 dissections were 2,1 and 0 %, respectively (p>0.05). Patients who underwent D2 dissection had significantly longer median operation time, more blood loss and more transfusion required in comparison to patients who underwent D1 dissection. The overall morbidity associated with surgery is found to be at a rate of 15,1 %. There was no significant difference between the two groups with regard to the major complications. However, when minor complications were assesed, a significant increase in the D2 group was observed. The overall mortality rate was calculated as 0.89 %. Conclusion: In our study, although extensive dissection had an increased morbidity, there was no significant statistical difference between the two procedures. As a conclusion, we think that D2 dissection can be carried out with safety in centers with experience.

Özet

Amaç: Mide kanserinde şifa bulma şansı ancak küratif cerrahi rezeksiyon ile mümkündür. Bu çalışmada D1 diseksiyon ile D2 diseksiyon arasında morbidite ve mortalite sonuçlarımızı retrospektif olarak analiz etme amaçlanmıştır. Yöntem: 2000–2009 yılları arasında mide kanseri tanısı konan, D1 ve D2 diseksiyon yapılan toplam 112 hasta retrospektif olarak çalışmaya alındı. Ameliyat prosedürü ve patolojik evreleme Japon gastrik kanser sınıflamasına göre yapıldı. Postoperatif mortalite ve morbidite retrospektif olarak analiz edildi. Bulgular: Kliniğimizde mide kanseri tanısı alan 131 hastanın verileri retrospektif olarak incelendi. Çalışma kriterlerine uygun bulunan 112 hasta çalışmaya dâhil edildi. Kalan 112 hastanın 47'sine D1, 65'ine D2 diseksiyon uygulandı. Genel operatif mortalite oranları D1 diseksiyonda % 2,1 ve D2 diseksiyonda % 0 idi (p>0,05). D2 diseksiyonun ortalama ameliyat süresi, kan kaybı ve transfüzyon ihtiyacı D1 diseksiyon yapılan gruba göre anlamlı olarak daha fazla idi. Ameliyatla ilişkili morbidite değerlendirildiğinde, genel olarak % 15,1 oranında bir morbidite ile karşılaşılmıştır. Major komplikasyonlar değerlendirildiğinde anlamlı bir fark gözlenmezken, minor komplikasyonlar değerlendirildiğinde D2 grubunda anlamlı bir artış izlenmiştir. Genel mortalite oranı % 0,89 olarak tespit edildi. Sonuç: Bu çalışmada morbidite geniş diseksiyonda artış göstermiş olmasına rağmen anlamlı bir fark oluşturmamaktadır. Sonuç olarak D2 diseksiyonun deneyimli merkezlerde güvenli bir şekilde yapılabileceğini düşünmekteyiz.

🔖

Cite This Article

YÜKSEL, B. C., UÇAR, N. S., YILDIZ, Y., BERKEM, H., ÖZEL, H., HENGİRMEN, S. (2009). The results of D1 versus D2 dissection in the management of gastric cancer was evaluated retrospectively for morbidity and mortality. Ulusal Cerrahi Dergisi, Cilt: 25 - Sayı: 3, 87–91. https://ajindex.com/articles/325535

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Coleman MP, Damiecki P, Arslan A, Renard H. Trends in Cancer Incidence and Mortality. In: IARC Scientific Publications: 1993
  2. Allum WH, Griffin SM, Watson A, et al. Guidelines for the management of oesophageal and gastric cancer. Gut 2002; 50: 1–23
  3. Sano T, Sasako M, Yamamoto S, Nashimoto A, Kurita A, Hiratsuka M, Tsujinaka T, Kinoshita T, Arai K, Yamamura Y, Okajima K. Gastric Cancer Surgery: Morbidity and Mortality Results from a Prospective Randomized Controlled Trial Comparing D2 and Extended Para- Aortic Lymphadenectomy-Japan Clinical Oncology Group Study 9501. J Clin Oncol 2004; 22, 14, 2767-2773
  4. NHS Executive: Guidance on Commissioning Cancer Services: Improving outcomes in uppergastro-intestinal cancers, 2001.http://www.dh.gov.uk/asset- Root/04/08/02/78/04080278.pdf 5) Çetiner S, Tan A, Sarıçam T, Yakut M, Kaymakçıoğlu N, Akdeniz A. Mide kanserinde genişletilmiş lenf nodu diseksiyonunun yeri. Ulusal Cerrahi Dergisi 1999;3:149-156 6) Sasako M, McCulloch P, Kinoshita T, Maruyama K. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg 1995; 82:346-351 7) Parikh D, Johnson M, Chagla L, Lowe D, McCulloch P.: D2 gastrectomy: Lessons from a prospective audit of the learning curve. Br J Surg 1996, 83:1595-1599
  5. International Union against Cancer: TNM Classification of Malignant Tumors (Ed 6). New York, NY, Wiley-Liss, 2002
  6. Kajitani T: Japanese Research Society for the Study of Gastric Cancer. The general rules for gastric cancer study in surgery and pathology. Jpn J Surg 1981;11:127- 10) Japanese Research Society for Gastric Cancer: Japanese Classification of Gastric Carcinoma (1st English Ed). Tokyo, Japan, Kanehara, 1995
  7. Sano T, Katai H, Sasako M, Maruyama K. One thousand consecutive gastrectomies without operative mortality. Br J Surg 2002;89:123
  8. Buğra D. Mide Kanserinde Genişletilmiş Lenf Bezi Disseksiyonu Sağ Kalım, Morbidite ve Mortalite Üzerine Etkileri. Ulusal Cerrahi Dergisi 1999; 5:269-281 13) Siewer JR, Böttcher K, Stein HJ, Roder JD. Relevant prognostic factors in gastric cancer: Ten year results of the German gastric cancer study. Ann Surg 1998; 228:449-461
  9. Hartgrink HH, van de Velde CJ, Putter H, Bonenkamp JJ, Klein Kranenbarg E, Songun I, Welvaart K, van Krieken JH, Meijer S, Plukker JT, van Elk PJ, Obertop H, Gouma DJ, van Lanschot JJ, Taat CW, de Graaf PW, von Meyenfeldt MF, Tilanus H, Sasako M. Extended lymph node dissection for gastric cancer: Who may Bene